scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. Inside Grand Rounds' $175 million funding round

Inside Grand Rounds' $175 million funding round

Lydia Ramsey Pflanzer   

Inside Grand Rounds' $175 million funding round
LifeScience2 min read

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hello,

Happy Monday!

Over the weekend, AstraZeneca and Oxford resumed their coronavirus vaccine trial and Gilead Sciences struck a $21 billion deal for cancer drugmaker Immunomedics.

Here's what else is happening in healthcare news:

Inside a Carlyle-led $175 million investment in digital-healthcare firm Grand Rounds: How the deal came together and what it says about the future of healthcare.

Read the full story from Casey Sullivan here>>

Fauci says Americans need to 'hunker down and get through this fall and winter,' or else play a game of whack-a-mole with the COVID-19 virus

Read the full story from Isabella Jibilian here>>

I led treatment of the first confirmed COVID-19 case in the US. We need universal mask wearing — here's how we can get everyone to wear one.

Read the full story from Dr. Amy Compton-Phillips here>>

More stories we're reading:

Subscribe to this newsletter here!

- Lydia

READ MORE ARTICLES ON


Advertisement

Advertisement